Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy
Abstract Background To investigate the impact of programmed death‐ligand 1 (PD‐L1) polymorphisms on the prognosis of non‐small cell lung cancer (NSCLC) patients treated with curative radiotherapy. Methods Four single nucleotide polymorphisms (SNPs) (rs822336G>C, rs822337T>A, rs822338C>T, an...
Enregistré dans:
Auteurs principaux: | Min Kyu Kang, Shin Yup Lee, Jin Eun Choi, Sook Kyung Do, Moon‐June Cho, Jun‐Sang Kim, Jae Yong Park |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9fb4f3f87b164d22987a18702f7ec04d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer
par: Yu Chen, et autres
Publié: (2021) -
Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy
par: Shubin Chen, et autres
Publié: (2021) -
Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non‐small cell lung cancer patients treated with radiotherapy
par: Moonkyoo Kong, et autres
Publié: (2021) -
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
par: Shijie Shang, et autres
Publié: (2021) -
Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy
par: Yanhao Liu, et autres
Publié: (2021)